SBI Securities
SNTI icon

SBI Securities’s Senti Biosciences Holdings SNTI Stock Holding History

SBI Securities’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$163 Buy
523
+189
+57% +$87 ﹤0.01% 3463
2026
Q2 		$367 Hold
334
– – ﹤0.01% 3142
2026
Q1 		$271 Sell
334
-2
-0.6% -$2 ﹤0.01% 3108
2025
Q4 		$349 Hold
336
– – ﹤0.01% 3006
2025
Q3 		$474 Sell
336
-2
-0.6% -$3 ﹤0.01% 2992
2025
Q2 		$713 Hold
338
– – ﹤0.01% 2821
2025
Q1 		$1.14K Buy
338
+1
+0.3% +$4 ﹤0.01% 2527
2024
Q4 		$1.18K Buy
+337
New +$1.08K ﹤0.01% 2536

Other funds holding SNTI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Menlo Ventures Management
Menlo Ventures Management Menlo Park, California $241M AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

SBI Securities's SNTI Position: Q3 2026 in Review

SBI Securities increased its Senti Biosciences Holdings (SNTI) stake by 57% in Q3 2026, buying an estimated $87 and bringing the position to 523 shares worth $163. The position accounts for ﹤0.01% of the portfolio, ranked #3463.

SBI Securities first reported a position in SNTI in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.18K in Q4 2024. 13 funds tracked by Wall St. Rank hold SNTI as of Q3 2026.

  • SBI Securities held 523 shares of Senti Biosciences Holdings worth $163 as of Q3 2026.
  • SBI Securities bought 189 Senti Biosciences Holdings shares in Q3 2026, an estimated $87.
  • Senti Biosciences Holdings made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3463 holding.
  • SBI Securities first reported a position in Senti Biosciences Holdings in Q4 2024 and has held it in 8 quarters since.
  • SBI Securities's Senti Biosciences Holdings position peaked at $1.18K in Q4 2024.
  • 13 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.